Currently holds positions in Boston Scientific Corp and Baxter International Inc
Position | Company | Period |
---|---|---|
Chairman of the Board, President, Chief Executive Officer | Boston Scientific Corp | April 15, 2016 - |
Independent Director | Baxter International Inc | Oct. 21, 2015 - |
President, Chief Executive Officer, Director | Boston Scientific Corp | Nov. 1, 2012 - April 15, 2016 |
President | Boston Scientific Corp | Oct. 17, 2011 - Nov. 1, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-05-02 | 2024-05-02 |
CVS Health Corp
(CVS)
|
B Purchase |
9,181
+5246.3%
54.49500,294 USD |
9,181 +5246.3% | 54.49 | 500,294 USD | |
2023-11-07 | 2023-11-06 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
113,356
-7.0%
52.515,951,983 USD |
113,356 -7.0% | 52.51 | 5,951,983 USD | |
2023-10-10 | 2023-10-09 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
113,355
-7.0%
52.095,904,481 USD |
113,355 -7.0% | 52.09 | 5,904,481 USD | |
2023-09-12 | 2023-09-12 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
113,355
-7.0%
53.916,110,447 USD |
113,355 -7.0% | 53.91 | 6,110,447 USD | |
2022-11-08 | 2022-11-07 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
125,827
-6.6%
41.975,280,997 USD |
125,827 -6.6% | 41.97 | 5,280,997 USD | |
2022-10-04 | 2022-10-03 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
125,827
-6.6%
39.344,949,556 USD |
125,827 -6.6% | 39.34 | 4,949,556 USD | |
2022-09-07 | 2022-09-06 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
125,828
-6.6%
40.495,094,310 USD |
125,828 -6.6% | 40.49 | 5,094,310 USD | |
2022-08-09 | 2022-08-08 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
125,828
-5.6%
40.975,154,682 USD |
125,828 -5.6% | 40.97 | 5,154,682 USD | |
2021-11-02 | 2021-11-01 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
201,042
-8.8%
43.058,655,682 USD |
201,042 -8.8% | 43.05 | 8,655,682 USD | |
2021-10-05 | 2021-10-04 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
103,204
-4.7%
43.394,477,929 USD |
103,204 -4.7% | 43.39 | 4,477,929 USD | |
2021-10-05 | 2021-10-04 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
97,838
-4.3%
42.434,151,110 USD |
97,838 -4.3% | 42.43 | 4,151,110 USD | |
2020-11-04 | 2020-11-03 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
259,207
-11.7%
35.069,087,227 USD |
259,207 -11.7% | 35.06 | 9,087,227 USD | |
2016-08-02 | 2016-08-01 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
44,400
-3.1%
24.441,084,994 USD |
44,400 -3.1% | 24.44 | 1,084,994 USD | |
2016-07-05 | 2016-07-01 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
100,000
-6.5%
23.432,342,570 USD |
100,000 -6.5% | 23.43 | 2,342,570 USD | |
2016-06-03 | 2016-06-01 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
100,000
-6.1%
22.692,268,650 USD |
100,000 -6.1% | 22.69 | 2,268,650 USD | |
2016-03-02 | 2016-03-01 |
Boston Scientific Corp
(BSX)
|
PS Planned sale |
100,000
-5.2%
16.961,695,600 USD |
100,000 -5.2% | 16.96 | 1,695,600 USD |